Academia edu 85177494 An Economic Model to Compare PDF An Economic Model to Compare Linezolid Vancomycin and Download Free PDF An Economic Model to Compare Linezolid Vancomycin and Teicoplanin for the Treatment of Confirmed Methicillin Resistant Staphylococcus Aureus
ResearchGate publication 267815100 PIN77 An Open access Full Text article an economic model to compare investigate the economic impact of linezolid compared with that of vancomycin in the treatment of hospitalized patients with MRSA confirmed NP in the German health care
Value in Health article S1098 3015 13 02092 5 An Economic Model to Compare Linezolid and Vancomycin for the To evaluate economic impact of linezolid LZD versus vancomycin VAN for treatment of confirmed methicillin resistant Staphylococcus aureus MRSA nosocomial pneumonia Author D A Patel A Michel J M Stephens B Weber X Gao C Charbonneau Publish Year 2013
ResearchGate publication 267815100 PIN77 An PDF PIN77 An Economic Model to Compare Linezolid and Oct 24 2014 Results The model calculated total base case inpatient costs of 15 116 for linezolid and 15 239 for vancomycin The incremental cost effectiveness ratio favored
OPEN Health publication library an economic An economic model to compare linezolid and vancomycin The model results show that linezolid is a cost effective alternative to vancomycin for MRSA confirmed NP largely attributable to the higher clinical response rate of
Pdf Pin77 An Economic Model To Compare Linezolid And
ResearchGate publication 313478126 Treatment of PDF Treatment of MRSA pneumonia Clinical and economic Jan 27 2017 An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin resistant Staphylococcus aureus nosocomial pneumonia in Germany
Semantic Scholar paper Cost Effectiveness of PDF Cost Effectiveness of Linezolid vs Vancomycin in Mar 9 2009 The cost benefit profile suggests that linezolid could be considered a cost effective alternative to vancomycin in the treatment of patients with NP caused by suspected
Dove Medical Press an economic model to compare linezolid An economic model to compare linezolid and vancomycin for the May 31 2014 This health economic model has been adapted for a German health care system and indicates that initiating treatment with linezolid is less costly and more efficacious
Pdf Pin77 An Economic Model To Compare Linezolid And
Academia edu 87743272 An Economic Model to Compare PDF An Economic Model to Compare Linezolid and Vancomycin Two large prospective randomized double blind trials demonstrated that linezolid 600 mg every 12 hours was noninferior in efficacy to fixed dose vancomycin 1 g
Economic model Simplified representations of economic reality
Mendeley catalogue 077d996f a6e6 3593 b387 05bd83 An economic model to compare line preview related info An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin resistant staphylococcus aureus nosocomial pneumonia in Germany People also search for